H.B. Fuller (NYSE:FUL – Free Report) – Investment analysts at Seaport Res Ptn reduced their Q1 2025 earnings estimates for shares of H.B. Fuller in a note issued to investors on Wednesday, March 5th. Seaport Res Ptn analyst M. Harrison now expects that the specialty chemicals company will post earnings per share of $0.43 for the quarter, down from their previous forecast of $0.45. Seaport Res Ptn currently has a “Hold” rating on the stock. The consensus estimate for H.B. Fuller’s current full-year earnings is $4.07 per share. Seaport Res Ptn also issued estimates for H.B. Fuller’s Q2 2025 earnings at $0.99 EPS and FY2025 earnings at $3.70 EPS.
A number of other analysts also recently issued reports on FUL. Citigroup reduced their price target on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. JPMorgan Chase & Co. reduced their price target on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd. Finally, Vertical Research downgraded shares of H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $75.60.
H.B. Fuller Stock Performance
Shares of NYSE FUL opened at $57.08 on Thursday. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.16 and a current ratio of 1.81. The company has a market cap of $3.12 billion, a P/E ratio of 24.71, a P/E/G ratio of 1.13 and a beta of 1.41. The firm’s fifty day moving average is $61.53 and its two-hundred day moving average is $71.93. H.B. Fuller has a 52-week low of $54.18 and a 52-week high of $87.67.
H.B. Fuller (NYSE:FUL – Get Free Report) last announced its quarterly earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). The company had revenue of $923.00 million during the quarter, compared to the consensus estimate of $916.84 million. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The business’s revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.32 earnings per share.
H.B. Fuller Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, February 20th. Investors of record on Thursday, February 6th were paid a dividend of $0.2225 per share. The ex-dividend date was Thursday, February 6th. This represents a $0.89 dividend on an annualized basis and a dividend yield of 1.56%. H.B. Fuller’s dividend payout ratio is presently 38.53%.
Hedge Funds Weigh In On H.B. Fuller
Large investors have recently made changes to their positions in the company. Lord Abbett & CO. LLC boosted its stake in shares of H.B. Fuller by 79.8% during the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after purchasing an additional 324,056 shares during the period. Geode Capital Management LLC boosted its stake in shares of H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after purchasing an additional 18,734 shares during the period. S&CO Inc. boosted its stake in shares of H.B. Fuller by 0.3% during the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after purchasing an additional 920 shares during the period. Wesbanco Bank Inc. boosted its stake in shares of H.B. Fuller by 41.2% during the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after purchasing an additional 4,000 shares during the period. Finally, MetLife Investment Management LLC boosted its stake in shares of H.B. Fuller by 4.7% during the 4th quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company’s stock worth $2,231,000 after purchasing an additional 1,472 shares during the period. 95.93% of the stock is owned by hedge funds and other institutional investors.
About H.B. Fuller
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Recommended Stories
- Five stocks we like better than H.B. Fuller
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- What is the Australian Securities Exchange (ASX)
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.